Praxis Precision Medicines Inc (PRAX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $340.47
• Market Cap: $9.64B
• EPS: $-12.96
• 52-Week High: $356.00
• 52-Week Low: $26.70

Market Sentiment

Praxis Precision Medicines Inc currently has a Bullish sentiment score of 0.38.

About Praxis Precision Medicines Inc

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing innovative therapies for central nervous system disorders linked to neuronal imbalance. Utilizing a proprietary scientific platform, Praxis aims to identify and advance novel treatments for a range of neurological conditions, prioritizing those with significant unmet medical needs. With a strong pipeline and a commitment to enhancing patient outcome...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Praxis Precision Medicines Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PRAX pay dividends?

Praxis Precision Medicines Inc (PRAX) does not currently pay a regular dividend.

What is PRAX's market cap?

Praxis Precision Medicines Inc (PRAX) has a market capitalization of $9.64B with a current stock price of $340.47.